Dr. Richard Harris attended the University of Chicago high school, Washington University in St. Louis and the Chicago Medical School. He did his residency in general surgery and urology at Loyola University Medical Center. He was a founding member and is now the CEO and President of UroPartners, an integrated urology/pathology/radiation oncology practice with over 60 physicians. He has been in the private practice of urology in Chicago for the last 30 years.
Harris has been involved in pharmaceutical research and has performed over 100 clinical trials in drug development. He has served on the board of LUGPA for the last 12 years and is the former President. His main interest in urology is prostate cancer and specifically metastatic castrate resistant prostate cancer. Harris is an assistant clinical professor of urology at Loyola University Medical Center.